Severe refractory atopic dermatitis with elevated serum IgE treated with omalizumab.

Switlyk, Stephen A; Taylor, Andrea L; Gaertner, Erich M

Switlyk, Stephen A; Taylor, Andrea L; Gaertner, Erich M.

Affiliation

Switlyk SA; Private practice, Sarasota, Florida, USA.
Taylor AL; Department of Dermatology, University of Florida, Gainesville, USA.

Cutis ; 99(4): E6-E8, 2017 04.

Article in En | MEDLINE | ID: mdl-28492605

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Dermatitis, Atopic/diagnosis; Omalizumab/therapeutic use; Antibodies, Monoclonal, Humanized/administration & dosage; Dermatitis, Atopic/blood; Dermatitis, Atopic/drug therapy; Diagnosis, Differential; Drug Administration Schedule; Humans; Immunoglobulin E/blood; Male; Middle Aged; Omalizumab/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic / Antibodies, Monoclonal, Humanized / Omalizumab Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Cutis Year: 2017 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links